However, the authors noted that GFAP was increased more (88%) than imidazoline receptor proteins (36%) in AD brains, suggesting an astrocyte phenotype which lacks I2-BS receptor sites and thus will not be detected by 11C-BU99008. The gene discussed is GFAP; the disease is Alzheimer disease.